Medical Equipment Clinical Trials This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory.

Medico-economic Interest of the Patient Matched Cutting Blocks (Ancillary) MyKnee ® LBS During the Poses of Complete Prosthesis of Knee GMK ®. Multicentric, Prospective, Controlled, Opened, Randomised Study About a Medical Device.
Condition: OsteoarthritisInterventions: Device: the prosthesis GMK ® without the ancillary MyKnee ® LBS; Device: Matched patient cutting blocks MyKnee ® LBSSponsors: Nantes University Hospital; Nantes University HospitalRecruiting - verified March 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2013 Category: Research Source Type: clinical trials

PwC's Health Research Institute Identifies the Top Ten Health Industry Issues to Watch in 2013
New HRI report provides insight into healthcare industry's focus in the year ahead; ACA implementation, healthcare coverage, employee benefits, the new pharma value proposition, increased consumerism, BYOD and medical device excise tax are... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 10, 2013 Category: Pharmaceuticals Source Type: clinical trials

FDA Clears Software That Helps Radiologists Rapidly and Accurately Confirm Placement of Lifesaving Medical Devices
DAYTON, Ohio--(BUSINESS WIRE)--Jan 9, 2013 - ClearRead +Confirm, new software from Riverain Technologies that improves the clarity of conventional chest X-ray images and allows radiologists to rapidly confirm the proper placement of tubes, lines... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 9, 2013 Category: Pharmaceuticals Source Type: clinical trials

Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne System
Results Set a High Standard in Sustained Long Term Clinical Outcomes SUNNYVALE, Calif.--(BUSINESS WIRE)--Oct 24, 2012 - Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 24, 2012 Category: Pharmaceuticals Source Type: clinical trials

Elixir Medical Announces Continued Excellent One Year Safety and Efficacy Data from the EXCELLA BD Randomized Clinical Trial for DESyne BD Novolimus Eluting Coronary Stent with Biodegradable Polymer
SUNNYVALE, Calif.--(BUSINESS WIRE)--May 15, 2012 - Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced one-year randomized clinical trial results... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - May 15, 2012 Category: Pharmaceuticals Source Type: clinical trials

Medtronic Endurant AAA Stent Graft Shows Durable Performance at Two Years in U.S. Study
Market-Leading Medical Device for Minimally Invasive Treatment of Abdominal Aortic Aneurysms Continues to Demonstrate Strong Safety and Efficacy MINNEAPOLIS & LONDON--(BUSINESS WIRE)--Apr 16, 2012 - Bolstering confidence in endovascular repair... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 16, 2012 Category: Pharmaceuticals Source Type: clinical trials

Etude Tomos- Apport de la Tomosynthèse Dans le Bilan d'Extension locorégional préthérapeutique d'Une Tumeur du Sein : Recherche de multicentricité Tomos Study- Contribution of Tomosynthesis In Locoregional Pretherapeutic Staging of a Breast Tumor: Multicentricity Search
Condition: Mammary TumorInterventions: Other: Evaluation of the Tomosynthesis; Other: Avaluation of a medical device: the tomosynthesisSponsor: Centre Jean PerrinRecruiting - verified January 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2012 Category: Research Source Type: clinical trials

Investigation of Efficacy and Outcome of a New Medical Device for Treatment of Migraine
Condition: MigraineInterventions: Device: In-house prototype invented by Jan-Erik Juto; Device: In-house prototype invented by Jan-Erik JutoSponsor: Karolinska University HospitalNot yet recruiting - verified December 2011 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2011 Category: Research Source Type: clinical trials

Investigation of Efficacy and Outcome of a New Medical Device for Treatment of Migraine
Condition: MigraineInterventions: Device: In-house prototype invented by Jan-Erik Juto; Device: In-house prototype invented by Jan-Erik JutoSponsor: Karolinska University HospitalRecruiting - verified January 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2011 Category: Research Source Type: clinical trials

Derma Sciences Reports Positive Top-Line Results from DSC127 Phase 2 Trial in Patients with Diabetic Foot Ulcers
Drug meets primary efficacy endpoint Wounds up to three times more likely to heal Conference call begins at 10:00 a.m. Eastern time today PRINCETON, N.J.--(BUSINESS WIRE)--Feb 3, 2011 - Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 4, 2011 Category: Pharmaceuticals Source Type: clinical trials

Derma Sciences to Hold Conference Call to Discuss Results from Phase 2 DSC127 Trial in Diabetic Foot Ulcers February 3
PRINCETON, N.J.--(BUSINESS WIRE)--Feb 2, 2011 - Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, will issue a news release announcing top-line efficacy results from its Phase 2 trial... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 2, 2011 Category: Pharmaceuticals Source Type: clinical trials

PharmaNet's Technology Investments Translate to Enhanced Client Service in Its Phase I Clinics
PRINCETON, N.J., Dec. 13, 2010 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 13, 2010 Category: Pharmaceuticals Source Type: clinical trials

Safety and Efficacy Study of the Z-Lig Medical Device Compared to Allograft
Condition: Ruptured Anterior Cruciate LigamentsInterventions: Device: Z-Lig; Device: allograftSponsor: Aperion Biologics, Inc.Recruiting - verified March 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2010 Category: Research Source Type: clinical trials

Safety and Efficacy Study of the Z-Lig Medical Device Compared to Allograft
Condition: Ruptured Anterior Cruciate LigamentsInterventions: Device: Z-Lig; Device: allograftSponsors: Aperion Biologics, Inc.; Aperion Biologics, Inc.Active, not recruiting - verified October 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2010 Category: Research Source Type: clinical trials